Home / Pharma Healthcare / Global Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Global Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2021

  • Id : RNR-43547
  • Category : Pharma Healthcare
  • Publish Date : Nov-16
  • Pages : 114
  • Format : PDF
License Type

Description
"Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

And main types of medicine are Itraconazole, Terbinafine, Fluconazole, Amorolfine, Ciclopirox.
"

Scope of the Report:
This report focuses on the Onychomycosis (Tinea Unguium) Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Pfizer
    Yangtze River
    Torrent Pharma
    J&J
    Chengdu Brilliant
    Novartis
    Qilu Pharmaceutical
    Hubei Hengan
    Xiuzheng Pharmaceutical
    Valeant Pharma
    TARO
    Perrigo
    Galderma
    Zhejiang Deyer
    Moberg

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
    Oral medication
    External medicine

Market Segment by Applications, can be divided into
    The Middle-aged
    Children
    The Aged

There are 13 Chapters to deeply display the global Onychomycosis (Tinea Unguium) Drug market.

Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Onychomycosis (Tinea Unguium) Drug, with sales, revenue, and price of Onychomycosis (Tinea Unguium) Drug, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Onychomycosis (Tinea Unguium) Drug, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Onychomycosis (Tinea Unguium) Drug market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Onychomycosis (Tinea Unguium) Drug sales channel, distributors, traders, dealers, appendix and data source.